BNP Paribas Financial Markets
OTLK icon

BNP Paribas Financial Markets’s Outlook Therapeutics OTLK Stock Holding History

BNP Paribas Financial Markets’s Portfolio OTLK Stock Details OTLK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$485 Hold
305
– – ﹤0.01% 5682
2026
Q1 		$63 Hold
305
– – ﹤0.01% 5711
2025
Q4 		$482 Hold
305
– – ﹤0.01% 5481
2025
Q3 		$323 Sell
305
-248
-45% -$429 ﹤0.01% 5343
2025
Q2 		$885 Sell
553
-393
-42% -$627 ﹤0.01% 5155
2025
Q1 		$1.15K Sell
946
-2,004
-68% -$3.51K ﹤0.01% 5051
2024
Q4 		$5.58K Sell
2,950
-70
-2% -$288 ﹤0.01% 4922
2024
Q3 		$16.1K Buy
3,020
+2,330
+338% +$17.1K ﹤0.01% 3768
2024
Q2 		$5.09K Sell
690
-3,815
-85% -$30.6K ﹤0.01% 3766
2024
Q1 		$53.8K Buy
4,505
+186
+4% +$1.5K ﹤0.01% 3563
2023
Q4 		$34K Sell
4,319
-21,773
-83% -$184K ﹤0.01% 3619
2023
Q3 		$115K Buy
26,092
+24,070
+1,190% +$533K ﹤0.01% 3286
2023
Q2 		$70.4K Sell
2,022
-1,222
-38% -$33.3K ﹤0.01% 3376
2023
Q1 		$70.7K Buy
3,244
+2,377
+274% +$53.2K ﹤0.01% 3381
2022
Q4 		$18.7K Buy
867
+364
+72% +$7.92K ﹤0.01% 3552
2022
Q3 		$12.3K Sell
503
-789
-61% -$18.3K ﹤0.01% 4158
2022
Q2 		$26.4K Buy
1,292
+821
+174% +$23.6K ﹤0.01% 3669
2022
Q1 		$16.8K Sell
471
-482
-51% -$15.1K ﹤0.01% 3748
2021
Q4 		$25.9K Buy
953
+151
+19% +$5.39K ﹤0.01% 3832
2021
Q3 		$34.8K Buy
802
+633
+375% +$30.5K ﹤0.01% 3587
2021
Q2 		$8.4K Buy
+169
New +$7.84K ﹤0.01% 3759

Other funds holding OTLK

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
GWM
Gilpin Wealth Management Denver, Colorado $145M AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SA
Sanctuary Advisors Indianapolis, Indiana $21.6B AUM 28.31% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

BNP Paribas Financial Markets's OTLK Position: Q2 2026 in Review

BNP Paribas Financial Markets held its Outlook Therapeutics (OTLK) position steady in Q2 2026 at 305 shares worth $485. The position accounts for ﹤0.01% of the portfolio, ranked #5682.

BNP Paribas Financial Markets first reported a position in OTLK in Q2 2021 and has held it in 21 quarters since. The position peaked at $115K in Q3 2023. 52 funds tracked by Wall St. Rank hold OTLK as of Q2 2026.

  • BNP Paribas Financial Markets held 305 shares of Outlook Therapeutics worth $485 as of Q2 2026.
  • BNP Paribas Financial Markets left its Outlook Therapeutics share count unchanged in Q2 2026.
  • Outlook Therapeutics made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #5682 holding.
  • BNP Paribas Financial Markets first reported a position in Outlook Therapeutics in Q2 2021 and has held it in 21 quarters since.
  • BNP Paribas Financial Markets's Outlook Therapeutics position peaked at $115K in Q3 2023.
  • 52 funds tracked by Wall St. Rank held Outlook Therapeutics as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.